Literature DB >> 10333999

Use of donepezil for vascular dementia: preliminary clinical experience.

M F Mendez1, F L Younesi, K M Perryman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10333999     DOI： 10.1176/jnp.11.2.268

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN： 0895-0172            Impact factor:   2.198


× No keyword cloud information.
  8 in total

Review 1.  Cholinergic therapy for neuropsychiatric symptoms in neurologic disorders.

Authors:  D I Kaufer
Journal:  Curr Psychiatry Rep       Date:  1999-10       Impact factor: 5.285

2.  Preservation of neurons of the nucleus basalis in subcortical ischemic vascular disease.

Authors:  San Jung; Chris Zarow; Wendy J Mack; Ling Zheng; Harry V Vinters; William G Ellis; Scott A Lyness; Helena C Chui
Journal:  Arch Neurol       Date:  2012-07

Review 3.  Poststroke aphasia : epidemiology, pathophysiology and treatment.

Authors:  Marcelo L Berthier
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 4.  Donepezil: in vascular dementia.

Authors:  David R Goldsmith; Lesley J Scott
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

5.  Poststroke Neuropsychiatric Illness: An Integrated Approach to Diagnosis and Management.

Authors:  James A. Bourgeois; Donald M. Hilty; Celia H. Chang; Mark A. Wineinger; Mark E. Servis
Journal:  Curr Treat Options Neurol       Date:  2004-09       Impact factor: 3.598

Review 6.  Cholinergic deficiency involved in vascular dementia: possible mechanism and strategy of treatment.

Authors:  Juan Wang; Hai-Yan Zhang; Xi-Can Tang
Journal:  Acta Pharmacol Sin       Date:  2009-07       Impact factor: 6.150

7.  Galantamine in the treatment of cognitive decline in patients with vascular dementia or Alzheimer's disease with cerebrovascular disease.

Authors:  Gary Small; Timo Erkinjuntti; Alexander Kurz; Sean Lilienfeld
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

8.  Cholinergic dysfunction in subcortical ischaemic vascular dementia: a transcranial magnetic stimulation study.

Authors:  Raffaele Nardone; Jürgen Bergmann; Frediano Tezzon; Günther Ladurner; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2008-01-11       Impact factor: 3.575
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.